Bachmann, H. S., Meier, W., du Bois, A., Kimmig, R., Kuhlmann, J. D., Siffert, W., . . . Wimberger, P. (2015). The FNTB promoter polymorphism rs11623866 as a potential predictive biomarker for lonafarnib treatment of ovarian cancer patients. Br J Clin Pharmacol.
Citação norma ChicagoBachmann, Hagen Sjard, et al. "The FNTB Promoter Polymorphism Rs11623866 As a Potential Predictive Biomarker for Lonafarnib Treatment of Ovarian Cancer Patients." Br J Clin Pharmacol 2015.
Deismireacht MLABachmann, Hagen Sjard, et al. "The FNTB Promoter Polymorphism Rs11623866 As a Potential Predictive Biomarker for Lonafarnib Treatment of Ovarian Cancer Patients." Br J Clin Pharmacol 2015.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.